Identification of Brain-Specific Treatment Effects in NPC1 Disease by Focusing on Cellular and Molecular Changes of Sphingosine-1-Phosphate Metabolism

Anne Gläser(Carl von Ossietzky Universität Oldenburg), Anja U. Bräuer(Charité - Universitätsmedizin Berlin)

International Journal of Molecular Sciences

June 24, 2020

10.3390/ijms21124502

Cited by 9

Related Papers

Neuronal 3′,3,5-Triiodothyronine (T <sub>3</sub> ) Uptake and Behavioral Phenotype of Mice Deficient in <i>Mct8</i> , the Neuronal T <sub>3</sub> Transporter Mutated in Allan–Herndon–Dudley Syndrome

|Journal of Neuroscience|2009|191

A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1

|Lipids in Health and Disease|2019|17